By John Halamka and Paul Cerrato—None of us are born with the ability to systematically weigh evidence or evaluate complex arguments, but learning these skills will have a profound impact on our personal and professional lives.

Mayo Clinic announced today additional capabilities within Mayo Clinic Platform_Orchestrate that make it more efficient for researchers to access standardized, real-world cancer data from Mayo[...]

By John Halamka and Paul Cerrato—Several AI algorithms are now available to improve patient care in Type 1 and Type 2 diabetes. Some of these digital tools may even personalize treatment using multimodal data.

When every second counts, preparation matters. See how a strategic collaboration supports a local neuroendovascular program to deliver advanced stroke care locally.

Augusta Health helped a patient with a rare diagnosis reclaim her health after consulting with experts through Mayo Clinic Care Network.

By John Halamka and Paul Cerrato—Patients seeking mental health diagnosis and treatment advice are not sure what digital tools to trust. Generative AI is not a panacea.

By John Halamka and Paul Cerrato—The next installment in our primer series uses plain English to explain what many thought leaders are calling a paradigm shift in medical AI.

By John Halamka and Paul Cerrato — A diagnosis of dementia often disrupts the lives of patients and their families. AI-enabled algorithms can provide a more definitive diagnosis, and in some cases help detect curable forms of the condition.

Mayo Clinic Care Network helps transform Wellstar’s service lines by using the ROW Forward framework for OR access and systemic challenges.

By John Halamka and Paul Cerrato —Kindness and empathy seem to be in short supply in today’s world. All the more reason to make the extra effort to demonstrate their power in our professional and personal lives.

By John Halamka and Paul Cerrato — Several life-threatening diseases have a major genetic component but gene testing for these conditions remains out of reach for many patients because current clinical guidelines don’t recommend the test. Why not?

By John Halamka and Paul Cerrato — Critics have questioned the objectivity of medical journal editors and peer reviewers, asking whether these “watchers” are preventing the best innovations from reaching professional readers.